Hong Kong Stock Movement | Danuo Medicine-B (06872.HK) rose more than 6% intraday on TNP-2092 Phase 2a proof-of-concept clinical trial results.

Zhito Finance APP has learned that TenNor Therapeutics-B (06872.HK) rose more than 6% during intraday trading. As of press time, it was up 3.99%, at HK$132.8, with a turnover of HK$64.2336 million.